Your session is about to expire
← Back to Search
Voice tremor for Muscle Tension Voice Disorder
N/A
Recruiting
Led By Kristina Simonyan, MD, PhD
Research Sponsored by Kristina Simonyan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
Summary
This trial is using a novel approach to study how brain changes and genetic risk factors are related in laryngeal dystonia, in the hopes of better understanding the disorder and improving clinical management.
Eligible Conditions
- Muscle Tension Voice Disorder
- Spasmodic Dysphonia
- Unaffected Relatives of Laryngeal Dystonia Patients
- Voice Tremor
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Brain changes in laryngeal dystonia
Secondary outcome measures
Genes responsible for laryngeal dystonia
Trial Design
4Treatment groups
Experimental Treatment
Group I: Voice tremorExperimental Treatment2 Interventions
Patients with voice tremor will undergo an MRI of the brain and a blood draw.
Group II: Unaffected relatives of laryngeal dystonia patientsExperimental Treatment2 Interventions
Unaffected relatives of patients with laryngeal dystonia will undergo an MRI of the brain and a blood draw.
Group III: Muscle tension dysphoniaExperimental Treatment2 Interventions
Patients with muscle tension dysphonia will undergo an MRI of the brain and a blood draw.
Group IV: Laryngeal DystoniaExperimental Treatment2 Interventions
Patients with laryngeal dystonia will undergo an MRI of the brain and a blood draw.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Blood draw
2021
Completed Phase 4
~7380
Find a Location
Who is running the clinical trial?
Kristina SimonyanLead Sponsor
3 Previous Clinical Trials
334 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
348 Previous Clinical Trials
180,327 Total Patients Enrolled
Kristina Simonyan, MD, PhDPrincipal Investigator - Massachusetts Eye and Ear Infirmary
Massachusetts Eye and Ear Infirmary
8 Previous Clinical Trials
1,824 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger